Key facts
- This page summarizes ELI LILLY & Co's Form 3 filing for TRex Bio, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Oct 2026, 21:39.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The reported securities consist of (i) 4,605,872 shares of Common Stock issuable upon mandatory conversion of convertible preferred stock and (ii) 875,000 shares of Common Stock being purchased by the Reporting Person in the Issuer's initial public offering.